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Abstract
Background: Pain is common in men undergoing rigid cystoscopy. Even with the application of a lubricant
containing 2 % lidocaine, about 76 % of men suffer from mild to severe pain when undergoing rigid cystoscopy.
The most painful part of the procedure for men is when the cystoscope passes through the membranous urethra.
Song et al. (Neurourol Urodyn 29:592–5, 2010) did autopsies on males and found that the dorsal nerve of the penis
(DNP), the terminal branch of the pudendal nerve, innervates the membranous urethra in 53.3 % of specimens. In
addition, the urethral mucosa has branches of innervated DNP. Dorsal penile nerve block (DPNB) is usually used for
circumcision in children, and it has been shown to provide effective analgesia for penile surgeries. In this study, we
hypothesized that DPNB could reduce the overall pain level in men during rigid cystoscopy.
Methods/design: The trial is a prospective, randomized, double-blind, placebo-controlled, single-center trial to
evaluate the effectiveness and safety of DPNB in analgesia for men undergoing rigid cystoscopy. Participants will be
enrolled and randomly allocated into one of three groups according to the different analgesia regimens: 1)
tetracaine gel group (DPNB with saline), 2) DPNB group (DPNB with ropivacaine plus plain lubricant), 3)
combination group (DPNB with ropivacaine plus tetracaine gel). The primary outcome of this study is the visual
analog scale (VAS, 0–10) for pain at cystoscopic inspection of the external sphincter. VAS scores evaluated at other
time points serve as secondary outcomes. Vital signs are secondary outcomes that address the discomfort and pain
during the procedure. Furthermore, the incidence of adverse events as secondary outcomes will also be recorded
for evaluation of the safety of DPNB in rigid cystoscopy. Clinical assessments will be evaluated prior to DPNB, at
administration of the lubricant gel, at cystoscopic inspection of the penile and bulbar urethra, external sphincter,
prostate, and bladder, as well as at withdrawal of the cystoscope.
Discussion: This research will determine the effectiveness and safety of DPNB in men undergoing rigid cystoscopy. The
results of this trial may have important implications for exploring the role of DPNB in analgesia for cystoscopy in men.
Trial registration: ClinicalTrials.gov identifier NCT02502487 (6 Jul 2015).
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Background
Cystoscopy is a kind of invasive manipulation often
used by urologists for diagnosis and treatment of
bladder cancer and other lower urinary tract diseases
[1, 2]. Flexible cystoscopy cause less discomfort and
pain than rigid cystoscopy, but it still cannot replace
the rigid cystoscopy technique because of the latter’s
lower cost and better optical area, and the fact that it
is easy to orient [3].
Pain and discomfort is common in men undergoing
rigid cystoscopy. Under general anesthesia, it was re-
ported that 30 % of patients complain of “feeling unwell”
within 1 week after rigid cystoscopy [4]. In outpatient
settings, even with application of a lubricant containing
2 % lidocaine, about 76 % of men suffer from mild to se-
vere pain when undergoing rigid cystoscopy, and ap-
proximately 27 % of patients could still feel mild to
moderate pain 7 days after the procedure [5].
Since the urethra is longer and narrower in men,
cystoscopy generally tends to be more painful for
them [6]. The most painful part of the procedure for
men is when the cystoscope passes through the mem-
branous urethra [7]. Song et al. [8] performed autop-
sies on males and found that the dorsal nerve of the
penis (DNP), the terminal branch of the pudendal
nerve, innervates the membranous urethra in 53.3 %
of specimens. In addition, the urethral mucosa is in-
nervated by branches of DNP [9].
Currently, dorsal penile nerve block (DPNB) is usu-
ally used for circumcision in children, and it has been
shown to provide effective analgesia for penile surgeries
since it was first reported by Kirya and Werthmann in
1978 [10]. To date, whether DPNB could be applied in
cystoscopy for analgesia has not been addressed. Since
some men have DNP branches innervating the mem-
branous urethra and urethra mucosa, we hypothesized




The trial is a randomized, double-blind, placebo-controlled,
single-center trial to evaluate the effectiveness and safety of
DPNB for analgesia in men undergoing rigid cystoscopy.
Participants will be randomized to one of three study
groups according to different analgesia regimens: 1) tetra-
caine gel group (DPNB with saline), 2) DPNB group
(DPNB with ropivacaine plus plain lubricant), 3) combin-
ation group (DPNB with ropivacaine plus tetracaine gel).
The trial scheme is illustrated in Fig. 1.
Ethics
This study was approved by the Clinical Trials and
Biomedical Ethics Committee of West China Hospital
of Sichuan University (Ref: 20150611) and was regis-
tered with the US National Institutes of Health Clin-
ical Trials registry (NCT02502487). This trial will be
performed according to the principles of the Declar-
ation of Helsinki (Edinburgh 2000 version). Written
informed consent will be obtained from each partici-
pant before enrollment.
Randomization
A set of random numbers for the allocation sequence
will be generated using a computerized SPSS software
package (version 18; SPSS Inc., Chicago, IL, USA).
Sealed, opaque assignment envelopes will be used for
allocation concealment. The included participants will
be randomly enrolled by sealed envelope and assigned
to one of three groups (tetracaine gel, DPNB, or com-
bination group) in a ratio of 1:1:1.
Blinding
A nurse, who will open the sealed envelopes, will
prepare the syringe containing either 0.3 ml/kg of
0.33 % ropivacaine (AstraZeneca Pharmaceutical, Inc.,
London, UK) or 0.3 ml/kg of saline for DPNB, and
10 ml of 1 % tetracaine gel (Xi’an Lijun Pharmaceut-
ical Co., Ltd., Xi’an, China) or 10 ml of liquid glycer-
ine (YunJia Medical Technology Co., Ltd., Harbin,
China) for instillation. The participants, attending
anesthesiologist and urologist, as well as the re-
searchers will be not aware of the randomization. The
allocation concealment will not be exposed until the
final data analysis report is completed.
Participants
Study population
Male patients undergoing rigid cystoscopy aged 20–75
years will be recruited from West China Hospital of
Sichuan University. The trial will be ongoing from
August 2015 to March 2016.
Inclusion criteria
 American Society of Anesthesiologists (ASA)
Physical Status I–II
 Without history of urethral or prostatic surgery
 Without respiration or circulation disorders
 Without chronic pain
Exclusion criteria
 Allergy to local anesthetics
 Coagulation disorder or usage of antiplatelet drugs
 Infection at the site of DPNB puncture point
 Severe urethral stenosis
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Interventions
DPNB experimental group
For participants randomized to the DPNB group, a
DPNB will be performed with a 22-G needle and 0.3
ml/kg of 0.33 % ropivacaine. After skin preparation
and palpation of the arch of the lower border of the
symphysis pubis, the base of the penis is gently pulled
down and the needle is inserted on either side of the
midline just distal to the inferior ramus of the pubic
bone. The needle is advanced slowly, towards the
center of the penile shaft, until loss of resistance is
felt as it penetrates Scarpa’s fascia, where the local
anesthetic is deposited equally on each side. All
blocks will be performed by only one experienced at-
tending anesthesiologist, who is good at the block
procedure. Five minutes after DPNB, 10 ml of liquid
glycerine will be instilled in the DPNB group at least
3 min before rigid cystoscopy.
Experimental group using combination of DPNB and
tetracaine gel
In the DPNB and tetracaine gel combination group, a
DPNB with 0.33 % ropivacaine (0.3 ml/kg) is performed
as in the DPNB group. Five minutes after the DPNB, tet-
racaine gel is instilled, with a minimum dwell time of 3
min, before rigid cystoscopy.
Tetracaine gel control group
For men in the tetracaine gel group, DPNB is performed
with saline. Five minutes after DPNB, tetracaine gel is
instilled, with a minimum dwell time of 3 min, before
rigid cystoscopy.
Fig. 1 Trial scheme. DPNB, dorsal penile nerve block
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Outcomes
Primary outcome
The primary outcome of this study is intensity of pain
measured by a visual analog scale (VAS) at cystoscopic
inspection of the external sphincter. VAS is an inter-
nationally recognized pain scale with 11 points, ranging
from 0 (no pain) to 10 points (maximal pain). Pain can
be rated as the following categories: no pain (0 points),
mild pain (1–3 points), moderate pain (4–6 points), and
severe pain (7–10 points). Participants will be well edu-
cated regarding the VAS once enrolled and asked to rate
their pain level during the study.
Secondary outcomes
VAS scores, assessed prior to DPNB (baseline), at admin-
istration of lubricant, at cystoscopic inspection of the
penile and bulbar urethra, the prostate and the bladder,
and at withdrawal of the cystoscope, serve as secondary
outcomes. Additionally, vital signs (heart rate, blood pres-
sure, breath rate, and pulse oxygen saturation) are second-
ary outcomes that consider the discomfort and pain
during the procedure and will be evaluated at the same
time points as the VAS evaluation. Furthermore, the inci-
dence of adverse events (penile hematoma, penile erec-
tion, autonomic movement and local anesthetic toxicosis)
as secondary outcomes will also be recorded from the be-
ginning of DPNB to the end of cystoscopy for evaluation
of the safety of DPNB in rigid cystoscopy.
Data collection
Each participant’s characteristics such as age and body
weight as well as ASA grade, durations of DPNB and
rigid cystoscopy, VAS scores, vital signs, and the inci-
dence of adverse events during rigid cystoscopy will be
recorded in a designed data form by an investigator.
Sample size
The sample size calculation was based on the primary
outcome, the intensity of pain measured on the VAS at
cystoscopic inspection of the external sphincter. There
are no data regarding VAS score for men when the rigid
cystoscope passes through the membranous urethra. We
therefore conducted a pilot study to determine the sam-
ple size prospectively. Based on our pilot data and litera-
ture relevant to pain during male rigid cystoscopy [11],
assuming a standard deviation (SD) of 2.6, an α of 0.05,
and a power of 90 %, 56 patients in each group are re-
quired to demonstrate a clinically relevant difference of
1.6 units in VAS score at cystoscopic inspection of the
external sphincter.
Statistical analysis
Statistical analysis will be performed with the SPSS (ver-
sion 18; SPSS Inc., Chicago, IL) and SAS (version 9.3; SAS
Inst. Inc., Cary, NC). All statistical tests will be two-sided,
and the level of significance will be set at 0.05. Data with a
normal distribution will be expressed as mean ± SD and
tested by one-way ANOVA with Dunnett’s post hoc test
as appropriate. Continuous data without a normal distri-
bution will be expressed as median with interquartile
range and analyzed using the MIXED procedure of the
SAS statistical program for repeated measures followed by
Tukey-Kramer adjustments.
Discussion
Cystoscopy plays an important role in both diagnosis
and treatment in urology. The rigid cystoscope is still
applied in many health care centers because of its lower
cost and better optical area and because it is easy to ori-
ent compared with flexible devices. However, due to the
stiffness of the rigid cystoscope sheath, there is discom-
fort and even pain resulting from the friction between
the wall of the urethra or bladder mucosa and the
sheath, and patients sometimes cannot finish the cystos-
copy, leading to misdiagnosis or missed diagnosis of the
disease [1, 2]. Recently, topical intraurethral lidocaine
gel, which is used as a local anesthetic, is most com-
monly used in clinics to ease the pain of the patients,
and this gel also could play a role in lubricating the ur-
ethra. However, some reports indicated that pain and
discomfort is common in men undergoing rigid cystos-
copy even with topical administration of local anesthetic
or under general anesthesia [4–6]. Thus, an effective an-
algesia regimen seems to be urgent for men undergoing
rigid cystoscopy.
Men suffer more pain than women in cystoscopy. The
most painful part of the procedure for men is when the
cystoscope passes through the membranous urethra [7].
Since evidence suggests that some men have DNP
branches innervating the membranous urethra and ur-
ethra mucosa, could DPNB be effective in relieving the
pain for men undergoing rigid cystoscopy, especially
when the cystoscope passes through the membranous
urethra? To address this question, we designed this trial
to evaluate the effectiveness and safety of DPNB for an-
algesia in men undergoing rigid cystoscopy. The results
of this trial may have important implications for explor-
ing the role of DPNB in analgesia for cystoscopy in men.
Trial status
The trial is currently in recruitment phase. Trial comple-
tion is expected by March 2016.
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